# Double Point Ventures **Entity class:** Concept or analytic term **Type:** Investment firm **Collection:** [[collections/Neurotech|Neurotech]] **Primary source:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] ## Definition Double Point Ventures is identified as the lead investor in Synchron's November 2025 Series D financing. ## Relationships [[wiki/Double Point Ventures|Double Point Ventures]] is related to [[wiki/Synchron|Synchron]] through Series D financing and to [[wiki/Campbell Murray|Campbell Murray]] through firm leadership. <!-- BEGIN HUMANIZED RELATIONSHIPS 2026-09-11 --> This entry's documented connections are expressed in its definition and related-work routes, with provenance retained in the source-linked material. <!-- END HUMANIZED RELATIONSHIPS 2026-09-11 --> ## Source route [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[collections/Neurotech|Neurotech]] ## Related Work in the Corpus <!-- BEGIN HUMANIZED CORPUS ROUTES 2026-09-11 --> - In [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], **Synchron: The Minimally Invasive Counter-Geometry** provides the narrative context for **Double Point Ventures**: In November 2025, Synchron raised \$200 million in Series D funding led by Double Point Ventures (co-founder and managing partner Campbell Murray, MD), accelerating pivotal trials and commercial launch preparations. <!-- END HUMANIZED CORPUS ROUTES 2026-09-11 -->